Pulverizing Metastatic Melanoma Beyond the B-RAF and N-RAS Chunks

被引：0
|
作者：
Moschos, Stergios [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
ONCOLOGIST | 2012年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [31] B-RAF, naevi and melanoma: a complex relationship
    Kittler, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (05) : 931 - 932
  • [32] Hyperactivation of MEK-ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
    Kaplan, F. M.
    Shao, Y.
    Mayberry, M. M.
    Aplin, A. E.
    ONCOGENE, 2011, 30 (03) : 366 - 371
  • [33] Involvement of B-Raf in uveal melanoma development
    Kilic, E
    Brüggenwirth, HT
    Mooy, CM
    Verbiest, M
    de Klein, A
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U361 - U361
  • [34] Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
    F M Kaplan
    Y Shao
    M M Mayberry
    A E Aplin
    Oncogene, 2011, 30 : 366 - 371
  • [35] B-RAF signalling in endoplasmic reticulum stress-induced apoptosis of metastatic melanoma
    Hill, D. S.
    Armstrong, J. L.
    Birch-Machin, M. A.
    Lovat, P. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (04) : 909 - 909
  • [36] New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma
    Teuma, Cecile
    Perier-Muzet, Marie
    Pelletier, Solenne
    Nouvier, Mathilde
    Amini-Adl, Mona
    Dijoud, Frederique
    Duru, Gerard
    Thomas, Luc
    Fouque, Denis
    Laville, Maurice
    Dalle, Stephane
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 419 - 426
  • [37] New insights into renal toxicity of the B-RAF inhibitor, vemurafenib, in patients with metastatic melanoma
    Cécile Teuma
    Marie Perier-Muzet
    Solenne Pelletier
    Mathilde Nouvier
    Mona Amini-Adl
    Frédérique Dijoud
    Gérard Duru
    Luc Thomas
    Denis Fouque
    Maurice Laville
    Stéphane Dalle
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 419 - 426
  • [38] Resistance to B-RAF inhibitor is mediated by reactivation of MAPK pathway by FGFR3/Ras signaling in B-RAF V600E mutant melanoma
    Yadav, Vipin
    Zhang, Xiaoyi
    Liu, Jiangang
    Estrem, Shawn
    Li, Shuyu Dan
    Gong, Xue-Qian
    Buchanan, Sean
    Henry, James R.
    Starling, James J.
    Peng, Sheng-Bin
    CLINICAL CANCER RESEARCH, 2012, 18 (10)
  • [39] Molecular profile of hyalinizing trabecular tumours of the thyroid:: High prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations
    Salvatore, G
    Chiappetta, G
    Nikiforov, YE
    Decaussin-Petrucci, M
    Fusco, A
    Carney, JA
    Santoro, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (05) : 816 - 821
  • [40] Involvement of B-Raf in Ras-induced Raf-1 activation
    Mizutani, S
    Inouye, K
    Koide, H
    Kaziro, Y
    FEBS LETTERS, 2001, 507 (03) : 295 - 298
12345